StockMarketWire.com - UBS today reaffirms its buy investment rating on Mediclinic International Plc [LON:MDC] and cut its price target to 385p (from 395p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk